3645 Medical Net , Inc. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

3645

TSE Growth

Medical Net , Inc.

311

JPY

(+0.32%)

Dec 23, 3:30 pm JST

1.98

USD

Dec 23, 1:30 am EST

Result

PTS

outside of trading hours

ー

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
May, 2021	2,904	331	336	129	15.4	4	Jul 14, 2021	J-GAAP
May, 2022	3,745	445	449	380	43.4	4	Jul 13, 2022	J-GAAP
May, 2023	4,500	379	431	116	13.0	2.50	Jul 18, 2023	J-GAAP
May, 2024	5,252	298	322	5	0.7	3	Jul 12, 2024	J-GAAP
May, 2025 Guidance	6,400	330	305	136	15.0	3	Jul 12, 2024	J-GAAP
YoY	+21.9%	+10.7%	-5.3%	+2,620.0%	+2,178.8%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
May, 2020	Jul 11, 2019	3,000	100	101	64	0.75	J-GAAP
Results	Jul 14, 2020	2,917	106	103	79	0.75	J-GAAP
May, 2021	Jul 14, 2020	Available in future release
	Dec 11, 2020
	Jan 12, 2021
Results	Jul 14, 2021
May, 2022	Jul 14, 2021
	Oct 12, 2021
	Apr 14, 2022
Results	Jul 13, 2022
May, 2023	Jul 13, 2022
	Jun 29, 2023
Results	Jul 18, 2023
May, 2024	Jul 18, 2023
Results	Jul 12, 2024
May, 2025	Jul 12, 2024	6,400	330	305	136	3	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
May, 2006	176	－	Available in future release
May, 2007	315	+79.0
May, 2008	519	+64.8
May, 2009	785	+51.3
May, 2010	1,037	+32.1
May, 2011	1,195	+15.2
May, 2012	1,054	-11.8
May, 2013	1,163	+10.3
May, 2014	1,268	+9.0
May, 2015	1,258	-0.8
May, 2016	1,482	+17.8
May, 2017	1,480	-0.1
May, 2018	1,740	+17.6
May, 2019	2,236	+28.5
May, 2020	2,917	+30.5
May, 2021	2,904	-0.4
May, 2022	3,745	+29.0
May, 2023	4,500	+20.2
May, 2024	5,252	+16.7
May, 2025 Guidance	6,400	+21.9	330	+10.7	305	-5.3	15.0	+2,042.9

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
May, 2023	4,500	379	8.42	6.41	3.51	1.36	13.0
May, 2024	5,252	298	5.67	0.26	0.13	1.41	0.7
May, 2025 Guidance	6,400	330	5.16	7.38	3.50	1.65	15.0

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	5,252	445	449	380	43.4
Fiscal Year	May, 2024	May, 2022	May, 2022	May, 2022	May, 2022

First Half

Result

Guidance History

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jun - Nov, 2021	1,702	249	246	246	28.4	0	Jan 12, 2022	J-GAAP
Jun - Nov, 2022	1,997	177	205	116	13.1	0	Jan 13, 2023	J-GAAP
Jun - Nov, 2023	2,342	169	194	115	12.8	0	Jan 12, 2024	J-GAAP
Jun - Nov, 2024 Guidance	3,088	80	67	-5	-0.6	0	Jul 12, 2024	J-GAAP
YoY	+31.9%	-52.7%	-65.5%	－	－

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Nov, 2021	Jul 14, 2021	1,933	158	158	152	0*	J-GAAP
	Oct 12, 2021	1,712	158	158	152	0*	J-GAAP
Results	Jan 12, 2022	1,702	249	246	246	0*	J-GAAP
Nov, 2022	Jul 13, 2022	Available in future release
Results	Jan 13, 2023
Nov, 2023	Jul 18, 2023
Results	Jan 12, 2024
Nov, 2024	Jul 12, 2024	3,088	80	67	-5	0	J-GAAP

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
May, 2022	445	-13	342	-355	282	1,128	35.82	J-GAAP
May, 2023	379	367	429	-62	-17	1,513	43.64	J-GAAP
May, 2024	298	-166	119	-285	144	1,507	37.78	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 1st Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jun - Aug, 2022	971	85	95	50	5.7	46.3	Oct 14, 2022	J-GAAP
Jun - Aug, 2023	1,099	22	44	21	2.4	22.7	Oct 13, 2023	J-GAAP
Jun - Aug, 2024	1,358	-3	-3	-35	-3.9	ー	Oct 15, 2024	J-GAAP
YoY	+23.6%	－	－	－	－

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Sep - Nov, 2022	1,026	92	110	66	7.5	9.0	Jan 13, 2023	J-GAAP
Dec - Feb, 2022	1,128	83	80	23	2.6	7.4	Apr 14, 2023	J-GAAP
Mar - May, 2023	1,375	119	146	-23	-2.6	8.7	Jul 18, 2023	J-GAAP
Jun - Aug, 2023	1,099	22	44	21	2.4	2.0	Oct 13, 2023	J-GAAP
Sep - Nov, 2023	1,243	147	150	94	10.5	11.8	Jan 12, 2024	J-GAAP
Dec - Feb, 2023	1,313	62	57	-69	-7.7	4.7	Apr 12, 2024	J-GAAP
Mar - May, 2024	1,597	67	71	-41	-5.4	4.2	Jul 12, 2024	J-GAAP
Jun - Aug, 2024	1,358	-3	-3	-35	-3.9	-0.2	Oct 15, 2024	J-GAAP
YoY	+23.6%	－	－	－	－

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Sep - Nov, 2019	739	+78.5	Available in future release
Dec - Feb, 2019	731	+9.9
Mar - May, 2020	744	-4.1
Jun - Aug, 2020	618	-12.1
Sep - Nov, 2020	781	+5.7
Dec - Feb, 2020	757	+3.6
Mar - May, 2021	748	+0.5
Jun - Aug, 2021	803	+29.9
Sep - Nov, 2021	899	+15.1
Dec - Feb, 2021	889	+17.4
Mar - May, 2022	1,154	+54.3
Jun - Aug, 2022	971	+20.9
Sep - Nov, 2022	1,026	+14.1
Dec - Feb, 2022	1,128	+26.9
Mar - May, 2023	1,375	+19.2
Jun - Aug, 2023	1,099	+13.2
Sep - Nov, 2023	1,243	+21.2
Dec - Feb, 2023	1,313	+16.4
Mar - May, 2024	1,597	+16.1
Jun - Aug, 2024	1,358	+23.6	-3	－	-3	－	-3.9	－

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	1,597	150	150	147	17.1
Fiscal Year	May, 2024	Nov, 2021	Nov, 2023	Aug, 2021	Aug, 2021

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
May, 2022	193.19	54.1	3,149	1,703	1,629	0.45	Jul 13, 2022	J-GAAP
May, 2023	211.94	55.3	3,467	1,917	1,710	0.41	Jul 18, 2023	J-GAAP
May, 2024	210.85	47.8	3,989	1,907	1,693	0.54	Jul 12, 2024	J-GAAP
Jun - Aug, 2024	ー	47.4	3,886	1,842	1,631	0.55	Oct 15, 2024	J-GAAP

Medical Net , Inc.(3645) Financial Results